Aarti Drugs faces Supreme Court GST challenge
Aarti Drugs Limited is facing a Supreme Court challenge from the GST Department over a tax dispute involving a proposed IGST demand of ₹230.70 crore. The case follows a recent legal victory at the Bombay High Court, which may affect market sentiment.
pre-market1 source ↓written by the desknot a recommendation
- a penalty
- ₹20.72 cr
Aarti Drugs Limited is contesting a Special Leave Petition filed by the GST Department in the Supreme Court, challenging its recent win at the Bombay High Court. The dispute involves a proposed IGST demand of ₹230.70 cr for FY 2017-18 to FY 2021-22, with a penalty of ₹20.72 cr. This escalation may impact investor sentiment and stock performance.
Not investment advice. For informational purposes only.